iSpecimen Inc. (ISPC) News
Follow iSpecimen Inc. (ISPC) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 13 public stories across 10 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
iSpecimen Acquires Foldlab AI Products for Drug Discovery, Disease Monitoring
iSpecimen says the acquisition expands its business beyond a biospecimen marketplace with agentic AI tools for protein discovery and disease trend prediction.
EQUITY | Nov 05, 2026, 09:07 PM UTC
L
iSpecimen Supports Hospital Validation of New Chemistry Analyzer
Company coordinates collection of more than 1,700 human specimens to support new laboratory testing capabilitiesWoburn, Massachusetts--(. - September 29, 2026) - iSpecimen, a provider of human biospecimens, is supporting
NEWS | Sep 29, 2026, 12:08 PM UTC
L
iSpecimen gets Nasdaq extension until Nov. 25, 2026 to regain compliance
Nasdaq granted iSpecimen an extension until Nov. 25, 2026 to regain compliance with Listing Rule 5550(b) on minimum stockholders' equity. The company said it plans prior and planned financings to regain compliance.
REGULATION | Sep 10, 2026, 09:05 PM UTC
L
iSpecimen to acquire Foldlab AI assets for $4.5 million
iSpecimen entered an Asset Purchase Agreement to acquire Foldlab AI software, models, source code, data rights and related IP and assets. Deal value is $4.5 million, including $2.0 million in cash.
MNA | Sep 04, 2026, 08:54 PM UTC
L
iSpecimen enters asset purchase agreement with FoldLab AI on September 4
iSpecimen entered an asset purchase agreement with FoldLab AI, with the agreement date set for September 4.
EQUITY | Sep 04, 2026, 08:54 PM UTC
L
iSpecimen appoints Shahin Behroyan as CEO
iSpecimen appoints Shahin Behroyan as CEO. Katharyn Field will transition from CEO.
EQUITY | Aug 31, 2026, 09:44 PM UTC
L
iSpecimen appoints Shahin Behrozyan CEO; Katharyn Field to leave
iSpecimen appointed Shahin Behrozyan as CEO. Katharyn Field will leave her role.
EQUITY | Aug 31, 2026, 09:28 PM UTC
L
Small caps JZ, ISPC, FLUX, MMA, SGLY slump premarket
Small-cap names JZ, ISPC, FLUX, MMA and SGLY are listed as premarket negative movers, with ISPC cited for completing a large-scale international cancer research order and shipping samples within three weeks.
EARNINGS | Aug 21, 2026, 12:09 PM UTC
L
ISPC - iSpecimen Completes Large-Scale International Cancer Research Order; Samples Shipped Within Three Weeks
ISPC - iSpecimen Completes Large-Scale International Cancer Research Order; Samples Shipped Within Three Weeks
EQUITY | Aug 20, 2026, 08:05 PM UTC
M
iSpecimen Prices $5 Million Public Offering
iSpecimen announces $5 million public offering
EQUITY | Aug 06, 2026, 12:31 PM UTC
M
ALOY: Prices $100M Private Placement
ALOY prices private placement of common stock for gross proceeds of approximately $100 million
EQUITY | Jun 25, 2026, 09:49 AM UTC
M
EXR Prices $550M Notes
EXR prices $550 million of 4.900% senior notes due 2032, while ISPC files Form S-1 and TSHA proposes public offering of common stock and pre-funded warrants
EQUITY | Jun 24, 2026, 09:04 PM UTC
L
ISPC Files S-1
ISPC files Form S-1 for up to 1,544,402 shares of common stock and pre-funded warrants
EQUITY | Jun 24, 2026, 09:02 PM UTC